Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Masmoudi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
La Revue De Medecine Interne|May 27, 2022
A cheek lesionB Dilly, V Grémain, W Masmoudi, et al.
Annales De Dermatologie Et De Venereologie|February 19, 2022
Efficacy of nivolumab in the treatment of metastatic cutaneous squamous cell carcinoma in a kidney-transplant patient with a history of allograft rejectionS Bastos, W Masmoudi, C Pinard, et al.
The British Journal of Dermatology|October 17, 2020
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoidW Masmoudi, M Vaillant, S Vassileva, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
La Revue De Medecine Interne|May 27, 2022
A cheek lesionB Dilly, V Grémain, W Masmoudi, et al.
Annales De Dermatologie Et De Venereologie|February 19, 2022
Efficacy of nivolumab in the treatment of metastatic cutaneous squamous cell carcinoma in a kidney-transplant patient with a history of allograft rejectionS Bastos, W Masmoudi, C Pinard, et al.
The British Journal of Dermatology|October 17, 2020
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoidW Masmoudi, M Vaillant, S Vassileva, et al.
Pageof 1